{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-121331","form_type":"8-K","ticker":"OBIO","cik":"0001814114","company_name":"Orchestra BioMed Holdings, Inc.","filed_at":"2023-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.611602+00:00","generated_at":"2026-06-07T21:07:21.941490+00:00","sec_items":["1.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Orchestra BioMed amends registration rights agreement, delaying S-1 amendment and effectiveness deadlines","bullets":["Obligation to amend S-1 deferred to earlier of April 1, 2024 or 15 business days after filing 2023 10-K.","Effectiveness deadline pushed to 90 days after filing first amendment or 10 business days after SEC clearance.","Amendment involves Medtronic affiliate Covidien Group S.à.r.l. and other investors.","Replaces the prior amended registration rights agreement from January 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-121331","json":"https://secwatch.observer/filing/0001104659-23-121331.json","markdown":"https://secwatch.observer/filing/0001104659-23-121331.md","text":"https://secwatch.observer/filing/0001104659-23-121331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923121331/0001104659-23-121331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923121331/tm2331589d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T21:07:21.941490+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"116c226b1133869e7e84fabae984ed2da086ba39","claim":"Orchestra BioMed Holdings, Inc. amended Second Amended and Restated Registration Rights and Lock-Up Agreement with Covidien Group S.à.r.l. valued at Delayed obligation to amend registration statement and cause effectiveness (effective 2023-11-21).","evidence_excerpt":"On November 21, 2023, Orchestra BioMed Holdings, Inc. (the “Company”) entered into a Second Amended and Restated Registration Rights and Lock-Up Agreement with certain investors named therein (the “Amended Agreement”), which amended and restated the Amended and Restated Registration Rights and Lock-Up Agreement, dated January 26, 2023 (the “Original Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923121331/0001104659-23-121331-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"Covidien Group S.à.r.l."},{"label":"Value","value":"Delayed obligation to amend registration statement and cause effectiveness"},{"label":"Effective","value":"2023-11-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}